September 3, 2024 – Macro Biologics, Inc., is proud to attend, sponsor and present at the World Antimicrobial Resistance Congress 2024 in Philadelphia, PA on September 5th and 6th. Macro’s CEO & CSO, Michael P. Bevilacqua, MD, PhD, is scheduled to present on the potential for using Macro’s investigational products to help protect key gateways, or entry points, against early microbial invasion that can progress to serious local infections and sepsis.

 

To read more, you can view the press release here.